Cancer-associated fibroblasts: An emerging target against esophageal squamous cell carcinoma

L Qiu, J Yue, L Ding, Z Yin, K Zhang, H Zhang - Cancer letters, 2022 - Elsevier
Esophageal squamous cell carcinoma (ESCC) is one of the most common human
malignancies worldwide and is associated with high morbidity and mortality. More than 70 …

[HTML][HTML] Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study

FW Hamilton, M Thomas, D Arnold, T Palmer… - PLoS …, 2023 - journals.plos.org
Background Sepsis is characterised by dysregulated, life-threatening immune responses,
which are thought to be driven by cytokines such as interleukin 6 (IL-6). Genetic variants in …

[HTML][HTML] Leveling up the controversial role of neutrophils in cancer: when the complexity becomes entangled

RV Sionov - Cells, 2021 - mdpi.com
Neutrophils are the most abundant immune cell in the circulation of human and act as
gatekeepers to discard foreign elements that have entered the body. They are essential in …

Blockade of the protease ADAM17 ameliorates experimental pancreatitis

MI Saad, T Weng, J Lundy, LJ Gearing… - Proceedings of the …, 2022 - National Acad Sciences
Acute and chronic pancreatitis, the latter associated with fibrosis, are multifactorial
inflammatory disorders and leading causes of gastrointestinal disease-related …

[HTML][HTML] Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from Sweden

P Eriksson, O Skoglund, C Hemgren… - Frontiers in …, 2023 - frontiersin.org
The Janus kinase (JAK)–STAT signaling pathway is relevant in both Takayasu and giant cell
arteritis (GCA), and the use of JAK inhibitors (JAKi) in arthritis, psoriasis, and inflammatory …

[HTML][HTML] Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study

M Nolde, Z Alayash, SL Reckelkamm… - Frontiers in …, 2023 - frontiersin.org
Aim Interleukin 6 (IL-6) is considered to play a role in the dysbiotic host response in the
development of periodontitis. While the inhibition of the IL-6 receptor using monoclonal …

[HTML][HTML] Angiopathic activity of LRG1 is induced by the IL-6/STAT3 pathway

A Dritsoula, L Dowsett, C Pilotti, MN O'Connor… - Scientific reports, 2022 - nature.com
Abstract Leucine-rich α-2-glycoprotein 1 (LRG1) is a secreted glycoprotein that under
physiological conditions is produced predominantly by the liver. In disease, its local …

[HTML][HTML] STAT3 inhibitors: a novel insight for anticancer therapy of pancreatic cancer

X Li, W Jiang, S Dong, W Li, W Zhu, W Zhou - Biomolecules, 2022 - mdpi.com
The signal transducer and activator of transcription (STAT) is a family of intracellular
cytoplasmic transcription factors involved in many biological functions in mammalian signal …

[HTML][HTML] Interleukin-6 downregulates the expression of vascular endothelial-cadherin and increases permeability in renal glomerular endothelial cells via the trans …

YC Yang, H Fu, B Zhang, YB Wu - Inflammation, 2022 - Springer
The pathogenesis of IgA nephropathy (IgAN) is still unknown, but reportedly, interleukin 6 (IL-
6) is involved in this process. However, its role in damaging glomerular endothelial cells is …

Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases

YS Li, HC Ren, JH Cao - International Immunopharmacology, 2022 - Elsevier
Abstract Interleukin-6 (IL-6) is a highly pleiotropic glycoprotein factor that can modulate
innate and adaptive immunity as well as various aspects of metabolism, including glycolysis …